Search research articles
Contact Us
Filters
Showing results (161-170 of 254) with videos related to
Page
of 26
Sort By:
Nature Immunology
|
October 18, 2005
N-acetylglucosamine-6-O-sulfotransferases 1 and 2 cooperatively control lymphocyte homing through L-selectin ligand biosynthesis in high endothelial venules
Hiroto Kawashima, Bronislawa Petryniak, Nobuyoshi Hiraoka, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
April 18, 2009
Core2 1-6-N-glucosaminyltransferase-I deficiency protects injured arteries from neointima formation in ApoE-deficient mice
Huan Wang, Weiyu Zhang, Rong Tang, et al.
International Immunology
|
July 14, 2004
Endomucin, a sialomucin expressed in high endothelial venules, supports L-selectin-mediated rolling
Hidenobu Kanda, Toshiyuki Tanaka, Masanori Matsumoto, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy
|
August 2, 2012
The definition of healthcare-associated pneumonia (HCAP) is insufficient for the medical environment in Japan: a comparison of HCAP and nursing and healthcare-associated pneumonia (NHCAP)
Norihito Kaku, Katsunori Yanagihara, Yoshitomo Morinaga, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
April 18, 2021
A novel automated immunoassay for serum NY-ESO-1 and XAGE1 antibodies in combinatory prediction of response to anti-programmed cell death-1 therapy in non-small-cell lung cancer
Yumiko Sakai, Koji Kurose, Kanako Sakaeda, et al.
Cancer Chemotherapy and Pharmacology
|
August 25, 2007
Phase I study of vinorelbine and irinotecan in previously untreated patients with advanced non-small cell lung cancer
Nanae Tomonaga, Yoichi Nakamura, Hiroshi Soda, et al.
Cancer Chemotherapy and Pharmacology
|
October 15, 2013
Phase II trial of erlotinib in patients with advanced non‑small‑cell lung cancer harboring epidermal growth factor receptor mutations: additive analysis of pharmacokinetics
Kohei Motoshima, Yoichi Nakamura, Kazumi Sano, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
July 16, 2013
[A case of lung cancer pain relief and safe return home by strontium chloride]
Kohei Motoshima, Minoru Fukuda, Yumi On, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy
|
August 23, 2012
Detection of Legionella pneumophila serogroup 1 in blood cultures from a patient treated with tumor necrosis factor-alpha inhibitor
Norihito Kaku, Katsunori Yanagihara, Yoshitomo Morinaga, et al.
Cancer Chemotherapy and Pharmacology
|
February 8, 2006
A phase I trial of carboplatin and etoposide for elderly (>or=75 year-old) patients with small-cell lung cancer
Minoru Fukuda, Hiroshi Soda, Yoshifumi Soejima, et al.
Page
of 26
Search research articles
Search
Showing results (161-170 of 254) with videos related to
Sort By:
Page
of 26
Nature Immunology
|
October 18, 2005
N-acetylglucosamine-6-O-sulfotransferases 1 and 2 cooperatively control lymphocyte homing through L-selectin ligand biosynthesis in high endothelial venules
Hiroto Kawashima, Bronislawa Petryniak, Nobuyoshi Hiraoka, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
April 18, 2009
Core2 1-6-N-glucosaminyltransferase-I deficiency protects injured arteries from neointima formation in ApoE-deficient mice
Huan Wang, Weiyu Zhang, Rong Tang, et al.
International Immunology
|
July 14, 2004
Endomucin, a sialomucin expressed in high endothelial venules, supports L-selectin-mediated rolling
Hidenobu Kanda, Toshiyuki Tanaka, Masanori Matsumoto, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy
|
August 2, 2012
The definition of healthcare-associated pneumonia (HCAP) is insufficient for the medical environment in Japan: a comparison of HCAP and nursing and healthcare-associated pneumonia (NHCAP)
Norihito Kaku, Katsunori Yanagihara, Yoshitomo Morinaga, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
April 18, 2021
A novel automated immunoassay for serum NY-ESO-1 and XAGE1 antibodies in combinatory prediction of response to anti-programmed cell death-1 therapy in non-small-cell lung cancer
Yumiko Sakai, Koji Kurose, Kanako Sakaeda, et al.
Cancer Chemotherapy and Pharmacology
|
August 25, 2007
Phase I study of vinorelbine and irinotecan in previously untreated patients with advanced non-small cell lung cancer
Nanae Tomonaga, Yoichi Nakamura, Hiroshi Soda, et al.
Cancer Chemotherapy and Pharmacology
|
October 15, 2013
Phase II trial of erlotinib in patients with advanced non‑small‑cell lung cancer harboring epidermal growth factor receptor mutations: additive analysis of pharmacokinetics
Kohei Motoshima, Yoichi Nakamura, Kazumi Sano, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
July 16, 2013
[A case of lung cancer pain relief and safe return home by strontium chloride]
Kohei Motoshima, Minoru Fukuda, Yumi On, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy
|
August 23, 2012
Detection of Legionella pneumophila serogroup 1 in blood cultures from a patient treated with tumor necrosis factor-alpha inhibitor
Norihito Kaku, Katsunori Yanagihara, Yoshitomo Morinaga, et al.
Cancer Chemotherapy and Pharmacology
|
February 8, 2006
A phase I trial of carboplatin and etoposide for elderly (>or=75 year-old) patients with small-cell lung cancer
Minoru Fukuda, Hiroshi Soda, Yoshifumi Soejima, et al.
Page
of 26